CTKB Q1 2022 Earnings — Cytek Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

CTKBCytek Biosciences, Inc.

$553M

Q1 2022 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$35M+44.5% YoY

Gross Profit

$20M57.5% margin

Operating Income

-$2M-6.7% margin

Net Income

-$2M-5.8% margin

EPS (Diluted)

$-0.02

QoQ Revenue Growth

-9.8%

Cash Flow

Operating Cash Flow

-$1M

Free Cash Flow

-$2M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$486M

Total Liabilities

$78M

Stockholders' Equity

$407M

Cash & Equivalents

$363M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$35M	$24M	+44.5%
Gross Profit	$20M	$14M	+39.3%
Operating Income	-$2M	$1M	-308.2%
Net Income	-$2M	$102,000	-2081.4%

Revenue Segments

Product

$31M90%

Service

$4M10%

Geographic Segments

UNITED STATES

$20M58%

EMEA

$9M25%

Asia Pacific

$5M14%

Other

$1M3%